Literature DB >> 21146097

Termination of the CRESCENDO trial.

Shawn G Kwatra.   

Abstract

Mesh:

Substances:

Year:  2010        PMID: 21146097     DOI: 10.1016/S0140-6736(10)62255-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  3 in total

Review 1.  Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction.

Authors:  Matthias Barton; Oliver Baretella; Matthias R Meyer
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

2.  The uphill battle facing antiobesity drugs.

Authors:  M Daubresse; G C Alexander
Journal:  Int J Obes (Lond)       Date:  2014-09-12       Impact factor: 5.095

Review 3.  Cannabis use, abuse, and withdrawal: Cannabinergic mechanisms, clinical, and preclinical findings.

Authors:  Andrew J Kesner; David M Lovinger
Journal:  J Neurochem       Date:  2021-05-16       Impact factor: 5.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.